Maternal microchimerism protects hemophilia A patients from inhibitor development.

ABSTRACT:

SUBMITTER: Lu Y 

PROVIDER: S-EPMC7218421 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature